Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, has extended the term of a supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools and integrated systems for the large scale-analysis of genetic variation and function.
The amendment extends the term of the supply agreement from three years to five years, terminating in July 2016. Sequenom and its subsidiaries purchase Illumina's sequencing equipment and consumables for use in the cell-free detection of fetal chromosomal abnormalities in maternal blood.